Collaborative Molecular Epidemiology Study of Metabolic Dysregulation, DNA Methylation, and Breast Cancer Risk Among Nigerian Women: MEND Study Objectives and Design

被引：6

作者：

Akinyemiju, Tomi ^{[1
]}

Salako, Omolola ^{[2
]}

Daramola, Adetola ^{[2
]}

Alatise, Olusegun ^{[3
]}

Adeniyi, Adewale ^{[4
]}

Ogun, Gabriel ^{[5
]}

Ayandipo, Omobolaji ^{[5
]}

Olajide, Thomas ^{[2
]}

Olasehinde, Olalekan ^{[3
]}

Arowolo, Olukayode ^{[3
]}

Adisa, Adewale ^{[3
]}

Afuwape, Oludolapo ^{[5
]}

Olusanya, AraIola ^{[5
]}

Adegoke, Aderemi ^{[6
]}

Ojo, Akinlolu ^{[7
]}

Tollefsboll, Trygve ^{[8
]}

Arnett, Donna ^{[1
]}

机构：

[1] Univ Kentucky, Lexington, KY 40536 USA

[2] Lagos Univ, Teaching Hosp, Lagos, Nigeria

[3] Obafemi Awolowo Univ, Teaching Hosp, Ife, Nigeria

[4] Fed Med Ctr, Abeokuta, Nigeria

[5] Univ Ibadan, Ibadan, Nigeria

[6] Our Lady Apostle Catholic Hosp, Ibadan, Nigeria

[7] Univ Arizona, Tucson, AZ USA

[8] Univ Alabama Birmingham, Birmingham, AL USA

来源：

JOURNAL OF GLOBAL ONCOLOGY | 2019年 / 5卷

基金：

美国国家卫生研究院;

关键词：

AFRICAN-AMERICAN WOMEN; CARDIOVASCULAR-DISEASE; AGE; BRITISH; ASSOCIATION; PREVALENCE; PROGNOSIS; SURVIVORS; YOUNGER; WHITE;

D O I：

10.1200/JGO.18.00226

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PURPOSE To elucidate the role of metabolic dysregulation and associated DNA methylation changes on breast cancer risk and aggressive subtypes among Nigerian women. We describe the design and methods of a collaborative molecular epidemiology study of breast cancer in Nigerian hospitals. METHODS The Mechanisms for Novel and Established Risk Factors for Breast Cancer in Women of Nigerian Descent (MEND) study was designed as a matched case-control study of 350 patients, age 18 to 75 years, with newly diagnosed, treatment-naive breast cancer and 350 age-matched healthy controls from surrounding geographic areas. Patients with breast cancer seen for initial diagnosis at four large tertiary hospitals in southwest Nigeria and one affiliated private hospital were recruited. Healthy female controls were selected from a cohort of 4,000 healthy women recruited as part of the Human Heredity and Health (H3) in Africa Chronic Kidney Disease Case-Control Study in Nigeria. Tumor and adjacent normal tissue, and blood and saliva samples were collected for molecular and epigenetic assays. RESULTS Although recruitment is ongoing, a total of 416 patients have been recruited to date, with tumor and blood samples obtained from at least 310 patients. Data on age-matched (6 months) controls have also been obtained and harmonized. Lipid assays for 350 pathologically verified cases and 350 age-matched controls is underway, and pathologic characterization of tumors (including immunohistochemistry for subtyping) is ongoing. Data on DNA methylation for tumors and adjacent normal tissue are expected by the end of the study period. CONCLUSION The MEND study will provide a unique, high-quality source of data to evaluate the contribution of metabolic dysregulation such as obesity, diabetes, hypertension, and metabolic syndrome to the biology of breast cancer among Nigerian women and foster collaborative studies relevant for women of African descent globally. J Global Oncol. (C) 2019 by American Society of Clinical Oncology.

引用

页码：1 / 9

页数：9

共 40 条

[1] Relationship between socioeconomic status and metabolic syndrome among Nigerian adults [J].